Brought to you by 
Ethicon will distribute Omrix's sealant in Europe
17 Mar 2006
Executive Summary
The wound management division of J&J's Ethicon business has licensed long-term, exclusive rights to distribute Omrix Biopharmaceuticals SA's Quixil surgical sealant in Europe. Omrix will handle manufacturing of finished product.
Deal Industry
- Biotechnology
- Medical Devices
-
Medical Devices
- Biomaterials
-
Surgical Equipment & Devices
- Surgical Sealants
Deal Status
- Final
Deal Type
-
Alliance
- Includes Contract
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Ethicon will distribute Omrix's sealant in Europe
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice